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Abstract
Background: The Posttraumatic Stress Disorder (PTSD) Checklist (PCL, now PCL-5) has recently been revised to
reflect the new diagnostic criteria of the disorder.
Methods: A clinical sample of trauma-exposed individuals (N = 352) was assessed with the Clinician Administered
PTSD Scale for DSM-5 (CAPS-5) and the PCL-5. Internal consistencies and test-retest reliability were computed. To
investigate diagnostic accuracy, we calculated receiver operating curves. Confirmatory factor analyses (CFA) were
performed to analyze the structural validity.
Results: Results showed high internal consistency (α = .95), high test-retest reliability (r = .91) and a high correlation
with the total severity score of the CAPS-5, r = .77. In addition, the recommended cutoff of 33 on the PCL-5 showed
high diagnostic accuracy when compared to the diagnosis established by the CAPS-5. CFAs comparing the DSM-5
model with alternative models (the three-factor solution, the dysphoria, anhedonia, externalizing behavior and
hybrid model) to account for the structural validity of the PCL-5 remained inconclusive.
Conclusions: Overall, the findings show that the German PCL-5 is a reliable instrument with good diagnostic
accuracy. However, more research evaluating the underlying factor structure is needed.
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Background
The diagnosis of posttraumatic stress disorder (PTSD)
has undergone major changes with the transition
from the Diagnostic and Statistical Manual of Mental
Disorders, 4th edition (DSM-IV) to DSM-5 [1]. These
include an expansion from three to four symptom
clusters, the introduction of three new symptoms, and
the revision of some already existing symptoms (for
an overview, see [2]). As the transition from DSM-IV
to DSM-5 included substantial changes to the defin-
ition of PTSD, existing questionnaires used to assess
PTSD needed to be revised by adding new items for
symptoms added to the PTSD diagnosis, removing
items that are no longer part of the DSM-5 defin-
ition, and rephrasing some items.
The Posttraumatic Stress Disorder Checklist (PCL;
[3]) is one of the most widely used self-report ques-
tionnaire to asses PTSD and has now been revised to
correspond to the new DSM-5 criteria of PTSD
(PCL-5; [4]). Changes between the PCL for DSM-IV
and the PCL-5 include (a) adding three new items to
assess the new PTSD symptoms blame, negative emo-
tions, and reckless or self-destructive behavior, (b)
changing the rating from a 1-5 scale to a 0-4 scale,
(c) rewording of existing items to reflect the DSM-5
criteria, and (d) having only one PCL version instead
of three versions for military members, civilians and
specific events.
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Psychometric properties of the PCL-5
To our knowledge, four published studies to date have
validated the new PCL-5; three were conducted in mili-
tary or veteran samples ([5, 6, 7]; note that in reference
7 a preliminary version of the PCL-5 was used) and one
in a college student sample [8]. In addition to the ori-
ginal English PCL-5, a Swedish version [9] and a Chinese
version [10, 11] have also been examined.
Results show high internal consistencies for the total
scale (α = .90 - .96) as well as the four subscales (intru-
sions: α = .77 - .92; avoidance: α = .74 – .92; negative alter-
ations in cognitions and mood: α = .78 - .89; hyperarousal:
α = .75 - .84) [5, 6, 8, 9]. In addition, high re-test reliability
has been found in three studies (r = .66-.84) [6, 8, 9].
There is consistent evidence for high concurrent validity
of the PCL-5 in the sense of high correlations with other
symptom measures of PTSD (r = .84 - .87) [5–8]. Further-
more, some evidence supporting discriminant validity of
the questionnaire was found in that the PCL-5 score is
more strongly correlated with measures of related con-
structs (e.g., other measures of PTSD, depression, anxiety
symptoms) than those of unrelated constructs (e.g., per-
sonality features, alcohol abuse, psychopathy) [5, 6, 8]. In
sum, there is emerging data showing good psychometric
properties for the PCL-5.
Diagnostic utility of the PCL-5
According to its developers, one of the purposes of
the PCL-5 is to screen individuals for PTSD and
make a provisional PTSD diagnosis.1 In order to test
the diagnostic utility of the PCL-5 as a screening in-
strument, it appears necessary to compare it to a gold
standard structured clinical interview, such as the
Clinician-Administered PTSD Scale for DSM-5
(CAPS-5) [12]. To our knowledge, this has only been
reported in two studies to date, namely Marmar et al.
[7] with a preliminary version of the PCL-5 and in
Bovin et al. [6] where the PCL-5 was evaluated
against a CAPS-5 diagnosis of PTSD. Results showed
that cutoff scores of 31-33 on the PCL-5 showed the
best diagnostic utility in predicting CAPS diagnoses,
with no difference between the three scores (sensitiv-
ity = .88, specificity = .69, overall efficiency = .80) [6].
This is in line with the cutoff of 33 suggested by the
developers of the PCL-51. An alternative scoring
method for the PCL-5 is treating each item rated as
at least 2 (moderately) as a symptom endorsed and
then following the DSM-5 diagnostic rule to establish
a provisional PTSD diagnosis. When applying this
rule to the PCL-5, Bovin and colleagues [6] also
found good diagnostic agreement with the CAPS-5
(sensitivity = .81, specificity = .71, overall efficiency =
.78). Although this recent study suggests that the
PCL-5 possesses adequate diagnostic utility to be used
as screening instrument for PTSD, clearly more re-
search is needed comparing the PCL-5 to the gold
standard diagnosis established from a structured clin-
ical interview in additional samples.
Structural validity of the PCL-5
Based on confirmatory factor analytic (CFA) studies on
the structure of posttraumatic stress disorder (PTSD)
criteria [13, 14], the DSM-5 revised the diagnostic struc-
ture of PTSD from a three-factor-model with 17 symp-
toms to a four-factor-model comprising 20 symptoms.
Criterion B (reliving) underwent minor changes, criter-
ion C was separated into two criteria (active avoidance
and negative cognitions/moods) and in criterion D (al-
terations in arousal/ reactivity) a specification for anger
expression and an additional symptom of reckless or
self-destructive behaviour was included.
To our knowledge, seven published studies to date have
tested whether this 4-factor structure can be supported
when applying CFA to the PCL-5 [6, 8, 10, 15–18].2 In
most studies, the DSM-5 model showed poor fit with the
data. Even in the minority of studies where acceptable to
good fit was found for the DSM-5 model [5, 6, 16, 19],
there were other models that showed significantly better
fit. In sum, support for the four-factor DSM-5 model
when applied to the PCL-5 is poor.
Five alternative models have recently received most at-
tention in the empirical literature (see also Table 1 for an
overview of the different models). This includes (a) the
Dysphoria Model [20] that was modified from the original
model due to different and additional symptoms in the
DSM-5 and comprises the four factors re-experiencing,
avoidance, dysphoria, hyperarousal, (b) the five-factor Dys-
phoric Arousal Model [21], also modified due to the DSM-
5 changes, separating hyperarousal into the two distinct
clusters of dysphoric arousal and anxious arousal, (c) the
six-factor Anhedonia Model [10] extending the Dysphoric
Arousal Model by separating the Negative Alterations in
Cognition and Mood factor into two distinct factors repre-
senting changes in negative vs. positive affect, (d) the six-
factor Externalizing Behavior Model [19] also extending
the Dysphoric Arousal Model by separating the Dysphoric
Arousal factor into two separate factors of External
Arousal vs. Externalizing Behavior, and (e) a seven-factor
Hybrid Model [15] combining the Anhedonia and Exter-
nalizing Behavior Models described above.
In a number of studies, the two six factor models
(Anhedonia Model: [5, 6, 8, 15, 18]); (Externalizing
Model: [5, 15, 18, 19]) showed good fit with the data
and outperformed all models comprising fewer fac-
tors. However, the seven-factor Hybrid Model has
been found to be the best fitting model [5, 6, 8, 11,
15, 18]. In sum, the literature on the latent structure
of the DSM-5 symptoms as assessed by the PCL-5 is
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still unclear, although the Hybrid Model has recently
been supported most consistently.
Importantly, a recent study [22] examined the im-
pact of these different psychometric models on
prevalence rates and found a considerable variation
of PTSD rates depending upon the latent symptom
profile. This finding indicates that diagnostic impli-
cations of factor analytic modelling of the PTSD
symptom structure are to be considered in future
studies.
The current study
The aims of the current study were threefold. First,
we developed a German version of the PCL-5 and
tested its psychometric properties, i.e. reliability,
convergent validity and diagnostic utility. As evi-
dence on the diagnostic utility of the PCL-5 is still
sparse, we tested how sensitive and specific
provisional diagnoses of PTSD established from the
PCL-5 are when compared to the gold standard
CAPS-5 diagnoses. Finally, we tested the structural
validity of the German PCL-5 directly comparing the
DSM-5 model of PTSD to other models suggested
in the literature.
Methods
Procedure and participants
The investigated sample (N = 341) was diverse in terms of
demographic characteristics and reported various types of
traumatic events (see Table 2 for sample characteristics).
Inclusion criteria were exposure to at least one traumatic
event and at least one month elapsed since the trauma.
This was assessed via self-report on the LEC. Recruitment
took place in five different treatment centers specializing
in the treatment of trauma-related disorders through staff
describing the study to the patients and via newspaper an-
nouncement from June 2014 until December 2015. In
total, N = 566 participants with a lifetime trauma history
were informed about the study and n = 352 signed written
consent. Most of the participants were treatment-seeking
(n = 320), only n = 32 were recruited via newspaper an-
nouncement and were non-treatment seeking participants.
Finally, n = 341 completed the assessment and were in-
cluded in the analysis. Test-retest assessment was sent
only to those participants who had not started treatment
yet in the month following the first assessment (n = 80);
n = 47 treatment-seeking participants and n = 31 non-
treatment seeking participants completed the retest
(22.2%) three weeks after the first assessment.
Table 1 Item mapping for the alternative latent structure models
DSM-5
model
Dysphoria
model
Dysphoric Arousal
model
Anhedonia
model
Externalizing behavior
model
Hybrid
model
Three-Factor
model
1. Intrusive thoughts R R R R R R Factor 1
2. Nightmares R R R R R R Factor 1
3. Flashbacks R R R R R R Factor 1
4. Emotional cue reactivity R R R R R R Factor 1
5. Physical cue reactivity R R R R R R Factor 1
6. Avoidance of thoughts A A A A A A Factor 1
7. Avoidance of reminders A A A A A A Factor 1
8. Trauma-related amnesia NACM D NACM NACM NACM NA Factor 3
9. Negative beliefs NACM D NACM NACM NACM NA Factor 3
10. Distorted blame NACM D NACM NACM NACM NA Factor 3
11. Persistent negative emotional
state
NACM D NACM NACM NACM NA Factor 3
12. Lack of interest NACM D NACM AN NACM AN Factor 2
13. Feeling detached NACM D NACM AN NACM AN Factor 2
14. Inability to experience
positive emotions
NACM D NACM AN NACM AN Factor 2
15. Irritable/ angry AR D DA DA EB EB Factor 2
16. Recklessness AR AR DA DA EB EB Factor 2
17. Hypervigilance AR AR AA AA AA AA Factor 1
18. Exaggerated state AR AR AA AA AA AA Factor 1
19. Difficulty concentrating AR D DA DA DA DA Factor 1
20. Sleep disturbance AR D DA DA DA DA Factor 1
Note: R re-experiencing, A avoidance, NACM negative alterations in cognitions and mood, AR alterations in arousal and reactivity, AN anhedonia, DA dysphoric
arousal, AA anxious arousal, NA negative affect, EB externalizing behaviour
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Participants recruited in both ways were fully informed
about the purpose and procedures of the study before
providing written informed consent. The assessment for
both groups included a clinical interview and a question-
naire battery with a varying order of the measures. The
interview was conducted either by registered clinical
psychologists (two centers) or trained psychologists with
at least a bachelor’s degree (three centers). Interviewers
received an intensive two-day training workshop and
were continuously supervised throughout the study. The
study was approved by the institutional research ethics
committee of the University of Münster.
Measures
Trauma exposure was measured with the German ver-
sion of the Life Events Checklist for DSM-5 (LEC-5;
[23]), a self-report measure assessing exposure to 16
traumatic events and one additional item for any other
extraordinarily stressful event. Next, participants com-
pleted the German version of the PTSD Checklist for
DSM-5 (PCL-5; [4]). The PCL-5 is a self-report measure
and consists of 20 items that correspond to the DSM-5
criteria for PTSD. Participants report their intensity of
symptoms over the past month on a 5-point-scale ran-
ging from 0 = not at all to 4 = extremely. The translation
of the LEC-5 and PCL-5 included several steps. First, the
original version was translated into German. Next, the
translation was back-translated into English by a profes-
sional translator, and the back-translation was compared
to the original English version. Discrepancies were re-
solved and corrected until the German version was ad-
equate (see Additional file 1: Appendix A for the final
version of the measure).
The German version of the Clinician Administered
PTSD Scale for DSM-5 (CAPS-5) ([12]; German version:
[12, 24]) was administered to determine whether partici-
pants fulfilled the diagnostic criteria for PTSD according
to DSM-5 and to obtain an interviewer rating of the se-
verity of PTSD symptoms. The CAPS-5 is a structured
clinical interview assessing the presence vs. absence of
DSM-5-criteria and providing a symptom severity score.
Clinicians rated the frequency and intensity of each
symptom over the past month on a 5-point-scale ran-
ging from 0 = absent to 4 = extreme/ incapacitating.
To assess for comorbid depressive and general psycho-
pathological symptoms, the Beck Depression Inventory-
II (BDI-II; [25, 26]) and the Brief Symptom Inventory
(BSI; [27, 28]) were used. Both are widely used and well-
validated measures of depressive symptom severity [29]
and general psychopathology [30], respectively.
Data analysis
Analyses were conducted using SPSS 23.0 and Mplus
Version 7 [31]. We first computed descriptive statistics,
internal consistencies and test-retest reliabilities. Next,
we evaluated the convergent validity of the PCL-5 by
calculating the correlations between the PCL-5 total
scores and the CAPS-5. The amount of missing data on
the PCL was very low (less than 0.4% of all data points;
maximum number of missing items per person was 3).
In the case of missing items on the PCL, a sum score of
all valid items was computed, as this is the most conser-
vative estimate. In addition, receiver operating character-
istic (ROC) curves were calculated to identify diagnostic
accuracy for different cutoffs. We first tested the diag-
nostic utility of the cutoff 31, 32, and 33 suggested by
the instrument authors and empirically identified in by
Bovin and colleagues [6]. We then examined whether an
alternative cutoff existed that led to higher diagnostic ac-
curacy. We also tested the diagnostic agreement with
Table 2 Sample characteristics (N = 341)
Characteristic N (%) M (SD) Range
Age 37.54 (12.16) 18 – 76
Gendera
Female 192 (56.3%)
Male 148 (43.4%)
Marital Statusb
Single 189 (55.4%)
Married 111 (32.5%)
Divorced 33 (9.7%)
Widowed 4 (1.2%)
Childrenc
Yes 176 (51.7%)
No 156 (45.7%)
Employment Situationd
Not Working 75 (21.0%)
Working Part-Time 34 (10.0%)
Working Full-Time 137 (40.2%)
Retired 42 (12.3%)
Other 45 (13.2%)
Most Frequent Traumatic Eventse
Natural disaster 49 (14.7%)
Traffic Accident 143 (42.7%)
Other Accident 62 (18.7%)
Physical Assault 185 (54.9%)
Sexual Assault 142 (42.1%)
Combat 74 (22.4%)
PTSD according to CAPS-5f
Yes 207 (60.7%)
No 129 (37.4%)
Note: missing data an = 1 (0.3%); bn = 4 (1.2%); cn = 9 (2.6%); dn = 8 (2.3%);
eAccording to the LEC; multiple entries per person were possible; fn = 5 (1.5%)
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the CAPS-5 diagnoses for the alternative scoring method
using ROC. This method involves that each PCL-5 item
rated at least 2 (moderately) is treated as a symptom en-
dorsed and the DSM-5 diagnostic rule is then used to
establish a provisional PTSD diagnosis. To further ana-
lyse the diagnostic utility, we calculated the sensitivity
(probability that someone with a CAPS-5 diagnosis will
test positive on the PCL-5), specificity (probability that
someone without a CAPS-5 diagnosis will test negative
on the PCL-5), the positive predictive power (probability
that someone with a positive PCL-5 receives a CAPS-5
diagnosis), the negative predictive power (probability
that someone with a negative PCL-5 does not receive a
CAPS-5 diagnosis) and the overall efficiency (percentage
of cases correctly classified). All of these analyses were
conducted with SPSS 23.0.
Finally, CFA using the robust maximum likelihood pro-
cedure was conducted to evaluate six often reported struc-
tural models of PTSD (see Table 1) using Mplus. Missing
data were dealt with the full information maximum likeli-
hood (FIML) procedure. The model fit was evaluated with
the comparative fit index (CFI), the Tucker-Lewis-Index
(TLI), the root-mean square error of approximation
(RMSEA), and the standardized root mean square residual
(SRMR). A good (and adequate) fit is indicated by CFI and
TLI ≥ .95 (.90- < .95), RMSEA ≤.06 (.06-.08), and SRMR
≤.08 [32]. To compare nested models, we used a chi-square
difference test, for non-nested models, the Bayesian infor-
mation criterion (BIC) and the Akaike information criterion
(AIC) were used. A difference of 10 points represents a bet-
ter fit for the model with the lower BIC value [33].
Results
Descriptives
Participants reported an average sum score of 39.09
(SD = 19.99) on the PCL-5. Sixty-three percent of the
sample met or exceeded a recommended cut score of 33
for provisional PTSD diagnosis. According to the CAPS-
5, 61.6% of our sample met DSM-5 criteria for PTSD.
The CAPS-5 average severity score was 29.09 (SD =
16.42). Both symptom levels of depression as well as
general psychopathology were in the moderate range
(depressive symptoms: BDI-II: M = 22.51, SD = 14.35;
general psychopathology: BSI: M = 1.28; SD = 0.86).
Reliability
Internal consistency for the PCL-5 total score was high,
with α = .95 for the total scale and α .79 - .89 for the
subscales (see Table 3). Inter-item correlations were
computed as another measure for internal consistency
and ranged from .21 to .73, which can be regarded as ac-
ceptable [34] (M = .48; re-experiencing items: .55 - .72,
avoidance items: .65, negative alterations in cognitions
and mood items: .23 - .69, and alterations in arousal and
reactivity items: .27 - .73).
To analyse test-retest reliability, n = 78 participants were
re-assessed with the PCL-5 three weeks after the initial as-
sessment. The PCL-5 total score showed a good test-retest
reliability with rtt = .91. A paired t test revealed no signifi-
cant difference between both assessment times (Time 1:
M = 28.77, SD = 21.13, Time 2: M = 26.97, SD = 20.86,
t(77) = 1.78, p = .08). At item level, test-retest reliability
ranged from .59 to .86 with a median of .74, indicating
good consistency across both assessment times.
Convergent validity and diagnostic utility
A strong correlation between the PCL-5 total score and
the CAPS-5 total severity score was found (r = .77), indi-
cating good convergent validity.
Receiver operating characteristic (ROC) analyses
were computed with SPSS to specify sensitivity and
specificity of the PCL-5 total score when compared
to DSM-5 diagnoses established with the CAPS-5
(see Fig. 1). The accuracy of the PCL-5 total score
was found good with the area under the curve of
.85, 95% CI = [.81, .90]. When examining the cutoff
of 33 recommended in the literature, diagnostic effi-
ciency was acceptable (sensitivity = .86, specificity =
.68, overall efficiency = .79). Results were very simi-
lar when applying a cutoff of 31 or 32, respectively
(see Table 4). The PCL-5 symptom scoring method
also led to acceptable sensitivity, specificity and
Table 3 Scale-level descriptive statistics
Scale M SD Possible range Observed range α
PCL-5 39.09 19.99 0-80 0-80 .95
PCL-5 intrusions 10.58 5.83 0-20 0-20 .89
PCL-5 avoidance 4.58 2.60 0-8 0-8 .79
PCL-5 neg. Cognitions & emotions 12.87 7.44 0-28 0-28 .86
PCL-5 hyperarousal 11.10 6.21 0-24 0-24 .84
CAPS-5 29.10 16.42 0-80 0-70 .93
BDI-II 22.51 14.35 0-63 0-55 .95
BSI 1.28 0.86 0-4 0-3.62 .97
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overall efficiency, but performed slightly worse than
the cutoff of 33. There was no other cutoff leading
to a higher overall efficiency.
Structural validity
In order to test the structural validity of the German
PCL-5, six different models suggested in the literature
were tested (see Table 1). CFA analyses for the DSM-5
model and dysphoria model (see Table 5 for fit indices,
Table 6 for factor loading and Table 7 for factor intercor-
relations) showed only a moderate fit. Non-nested model
comparisons yielded a slightly better model fit for the
dysphoria model (RMSEA .09, 90% CI [.09 - .10], CFI
.89, TLI .87, SRMR .05) than for the DSM-5 model, indi-
cated by a ΔBIC of 14.15. For all other models (dys-
phoric arousal, anhedonia, externalizing behaviour,
hybrid model), linear dependencies were observed in
both analyses using the robust ML or the WLSMV esti-
mator; this indicates that the models did not fit our
data3 and could therefore not be interpreted.
Discussion
The first aim of the current study was to test the psy-
chometric properties of the German version of the PCL-
5. The study was conducted on a large clinical sample
with a high proportion of PTSD-positive participants.
Internal consistencies and re-test reliabilities for the total
scale and for all subscales were very high and compar-
able to those for the original PCL-5 [5, 6, 8]. In addition,
we found a high correlation between the total scale and
the severity rating derived from the CAPS-5, suggesting
strong construct validity. Taken together, the study pro-
vides strong preliminary evidence that the German PCL-
5 is a reliable and valid self-report instrument to assess
PTSD symptom severity.
Although one of the aims of the PCL-5 is to enable mak-
ing provisional PTSD diagnoses, to our knowledge only
one prior study has directly tested the diagnostic utility of
the questionnaire when compared to the gold-standard as-
sessment using a structured clinical interview. The second
aim of our study therefore was to test provisional diagnoses
based on the PCL-5 against diagnoses based on the CAPS-
5. Results showed that the recommended cutoff of 33 as
well as the symptom scoring method both showed good
diagnostic accuracy against a CAPS diagnosis however the
cutoff performed slightly better. Both criteria led to high
sensitivity (≥ .84), moderate specificity (≥ .66) and adequate
overall efficiency (.79). It should be noted, however, that
there are no universal criteria to decide what constitutes a
good performance of a screening instrument (see: [35, 36])
as the relative importance of sensitivity and specificity de-
pends on the nature of the diagnostic situation. Therefore,
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Fig. 1 Sensitivity and Specificity curve for PCL-5 scores predicting CAPS-5 diagnoses
Table 4 Diagnostic utility of different PCL cutoff scores
PCL-5 Cutoff Sensitivity Specificity PPP NPP OE % PTSD according to this criterion
31 .88 .66 .81 .77 .79 67%
32 .87 .67 .81 .76 .79 66%
33 .86 .68 .81 .75 .79 65%
PCL-5 symptom scoring .84 .68 .81 .73 .78 64%
Sensitivity probability that someone with a CAPS-5 diagnosis will test positive on the PCL-5, Specificity probability that someone without a CAPS-5 diagnosis will
test negative on the PCL-5, PPP positive predictive power, NPP negative predictive power, OE overall efficiency, PCL-5 symptom scoring: each PCL-5 rated at least
2 (moderately) is treated as a symptom endorsed and the DSM-5 diagnostic rule is then used to establish a provisional PTSD diagnosis
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there may be situations where higher specificity is needed,
e.g. due to reduced capacity for further assessment or treat-
ment. As shown in Fig. 1, the PCL-5 can be accommodated
to be used in these situations by choosing a higher cutoff,
although it should be noted that this naturally comes at the
cost of reduced sensitivity.
The final aim of our study was to test the underlying la-
tent structure of the questionnaire. In line with earlier
studies, the fit for the four-factor DSM-5 model was unsat-
isfactory. Most alternative models suggested in the litera-
ture could not be interpreted due to linear dependencies.
An explanation for this could be the rather high occurrence
of PTSD with a high diversity of trauma types and demo-
graphic characteristics in our sample. This is contrary to
other studies that focused primarily on certain trauma types
(e.g. military sample and veterans [5, 6]). Future studies
need to investigate a possible relationship between sample
characteristics and model fit.
In addition, in all tested models correlations between fac-
tors were high. Other studies also reported high factor cor-
relations in the range of .73 - .92 [15] and .69 - .97 [10],
respectively. To address the unsatisfactory fit of the tested
models, a different statistical approach (e.g. network ana-
lyses) appears suitable to investigate if a model of mutually
reinforcing symptoms is better to explain PTSD symptoms
than the common factor models. This approach has been
applied in a recent study [37] where strong connections be-
tween central PTSD symptoms (e.g. nightmares and flash-
backs) has been found; the most central symptoms in this
study has been negative trauma related emotions, flash-
backs, detachment and physiological reactivity.
With respect to the factor structure, previous studies also
led to variable results and model fit was usually not excel-
lent. Comparing the factor structure of our data to previous
studies, we find a better fit for the dysphoria model com-
pared to the DSM-5 model (see also e.g. [15]). However,
the hybrid model is usually reported as the best fitting
model (see e.g.[18]). It is conceivable that the heteroge-
neous results regarding the factor structure of the PCL-5
specifically and the dimensional nature of PTSD more gen-
erally are at least partly due to the fact that there were sig-
nificant differences in the composition of samples between
studies. None of the published studies to date has used a
truly representative sample, which would be a necessary
next step. In addition, samples differed regarding the aver-
age PTSD symptom severity, the PTSD rate, trauma type,
and demographic variables. Compared to earlier studies in
the field, our sample was characterized by a particularly
high PTSD rate and a predominance of treatment-seeking
individuals who had suffered from civilian trauma (as com-
pared to veteran samples in a number of earlier studies).
Future research using large representative samples (i.e.
Table 5 PCL-5 confirmatory factor analyses model results
Models χ2 Df CFI TLI SRMR RMSEA RMSEA 90%CI BIC AIC
DSM-5 661.61* 164 .89 .87 .049 .094 .087 - .102 20,459.19 20,206.29
Dysphoria 647.45* 164 .89 .87 .051 .093 .086 - .101 20,445.04 20,192.13
Note: χ2 chi square, df degree of freedom, CFI Comparative Fit Index, TLI Tucker Lewis Index, SRMR Standardized Root Mean Square Residual, RMSEA Root Mean
Square Error of Approximation, BIC Bayesian Information Criterion, AIC Akaike information criterion
* p < .001
Table 6 CFA standardized factor loadings
PTSD symptoms DSM-5
model
Dysphoria
model
B1. Intrusive thoughts .85 .85
B2. Nightmares .75 .75
B3. Flashbacks .74 .74
B4. Emotional cue reactivity .81 .82
B5. Physical cue reactivity .81 .81
C1. Avoidance of thoughts .78 .78
C2. Avoidance of reminders .83 .83
D1. Trauma-related amnesia .40 .40
D2. Negative beliefs .74 .73
D3. Distorted blame .66 .65
D4. Persistent negative emotional state .81 .81
D5. Lack of interest .72 .71
D6. Feeling detached .76 .75
D7. Inability to experience positive
emotions
.73 .72
E1. Irritable/ angry .57 .58
E2. Recklessness .47 .45
E3. Hypervigilance .76 .82
E4. Exaggerated state .81 .87
E5. Difficulty concentrating .79 .78
E6. Sleep disturbance .74 .73
Table 7 Correlations Among Factors for all tested models
DSM-5 model & dysphoria model
R A NACM/ D AR
R – .783 .886 .922
A .783 – .784 .760
NACM / D .911 .792 – .933
AR .849 .694 .870 –
Note: the top diagonal correlations are from the DSM-5 model, the lower
diagonal correlations are from the dysphoria model
Note: R re-experiencing, A avoidance, NACM negative alterations in cognitions
and mood, AR alterations in arousal and reactivity
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samples with heterogeneous trauma types and also clinical,
treatment seeking samples) is needed to provide more reli-
able results and formally test factorial invariance across
samples. In a further step network analyses could also help
to understand if the heterogeneous findings of the factor
structure can be explained by varying symptom connec-
tions in different PTSD subgroups.
Limitations
The current study shows a number of strengths, including
the test of a clinical sample with a high base rate of PTSD,
and the comparison of the PCL-5 with the CAPS-5. On
the other hand, a number of limitations are noteworthy.
Most importantly, the sample size was rather modest,
which may have impacted on the CFA results. In addition,
we were not able to directly compare subgroups (e.g. sam-
ples of military or veterans, samples of childhood trauma,
accidental trauma). Finally, we were unable to conduct
discriminant validity analyses due to the lack of appropri-
ate instruments in our study design.
Conclusions
Despite these limitations, the current study provides im-
portant first evidence for the German PCL-5 as a ques-
tionnaire with good reliability and high diagnostic utility.
This is the first study validating the German version of the
PCL-5. Results indicated that the PCL-5 is a sensitive, spe-
cific and reliable measurement for PTSD with high clinical
utility. Results regarding the factor structure underlying
the measure remain inconclusive as none of the models
tested showed a good fit to our data. Differences to earlier
findings may be due to differences in sample characteris-
tics. Most importantly, the results underscore the need to
systematically investigate the factor structure of the PCL-5
and PTSD symptoms in large representative samples.
Endnotes
1http://www.ptsd.va.gov/professional/assessment/
adult-sr/ptsd-checklist.asp, retrieved on 12 August 2016
2Note, however, that three studies [16, 18, 19] were
based on the same population.
3The linear dependency also remained when items
were recoded into binary items.
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